Verastem Oncology to Present at the 7th Annual Evercore ISI HealthCONx Conference
Verastem Oncology (Nasdaq: VSTM), a biopharmaceutical company committed to advancing new medicines for patients with cancer, today announced that its management team will participate in a fireside chat at the 7th Annual Evercore ISI HealthCONx Conference on Tuesday, December 3rd at 11:15 am EST.
A live webcast of the fireside chat can be accessed under "Events & Presentations" in the Investors & Media section of the company's website at www.verastem.com. A replay of the webcast will be archived on the website for approximately 90 days following the presentation.
About Verastem Oncology
Verastem Oncology (Nasdaq: VSTM) is a late-stage development biopharmaceutical company committed to the development and commercialization of new medicines to improve the lives of patients diagnosed with cancer. Our pipeline is focused on RAS/MAPK-driven cancers, specifically novel small molecule drugs that inhibit critical signaling pathways in cancer that promote cancer cell survival and tumor growth, including RAF/MEK inhibition and FAK inhibition. For more information, please visit www.verastem.com and follow us on LinkedIn.
Today Mediplanet launches their Women in Research campaign, aimed at addressing gender disparities in the U.S. research workforce. Making up 30% of the research workforce, women continue to face systemic challenges, including gender bias, lack of...
Product: Dips
Issue: Food - Allergen ? Peanut
Distribution: AlbertaBritish ColumbiaPossibly other provinces and territories
See the affected products and product photos for this recall
SOURCE Canadian Food Inspection Agency (CFIA)
-The first Korean company granted Breakthrough Therapy Designation (BTD) from the U.S. FDA-Clinical trials and results from a three-year follow-up show significant improvements compared to existing treatments-The BTD designation, achieved following...
Investing in Canadians' health is key to building a stronger Canada. In its first year, the Canadian Dental Care Plan (CDCP) has significantly improved access to affordable dental care. More than 3.4 million Canadians were approved to be part of the...
Product: Organic Almond Butter Cup
Issue: Food - Allergen ? Peanut
Distribution: National Online
See the affected products and product photos for this recall
SOURCE Canadian Food Inspection Agency (CFIA)
The official brand behind Prime Biome has issued a public advisory regarding unauthorized third-party resellers misrepresenting the product online. Reports of unverified vendors listing non-official versions of Prime Biome across various platforms...
